Skip to main content

Table 2 Age-adjusted odds ratios according to the Osteoprotegerin950 T/C genotype

From: A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer

  Age-adjusted odds ratio (95% CI, P) according to the Osteoprotegerin 950 T/C genotypea
Study group CC TC TT
Prostate cancer against control 1.00 0.60 (0.345–1.032,0.065) 0.73 (0.418–1.302,0.294)
Tumor stageb    
   Stage D against Stage A+B+C 1.00 1.72 (0.801–3.698, 0.164) 2.76 (1.289–5.938, 0.009)
   Stage C+D against Stage A+B 1.00 1.74 (0.937–3.253, 0.079) 2.03 (1.078–3.843, 0.028)
Tumor gradeb    
   High against Low +Intermediate 1.00 1.27 (0.649–2.498, 0.482) 1.48 (0.750–2.947, 0.256)
  1. a These data were adjusted for age.
  2. b The tumor stage and grade systems are the same as those in Table 1.
\